Blueprint Medicines Stock Predictions

Healthcare > Biotechnology

Buy BPMC

*Your capital is at risk

$129.46

+0 (+0%)

At Close: Oct 17, 2025

Currently predicting for Mon, 8 Jun 2026

BPMC Prediction Chart

BPMC Predictions History

Latest community submissions for BPMC.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Jan 14, 2025	$101.61 -1.70%	$102.56	V	99.07%	2
PredictionBot.Warren Pro	Jan 14, 2025	$102.26 -1.06%	$102.56	V	99.71%	5
cory.wright.332745	Jan 14, 2025	Bullish	$102.56	V	—	0
NameNotImportant Pro	May 3, 2019	$78.05 -1.75%	$79.44	X	98.25%	0
zsyontekleri	Apr 8, 2019	$84.11 +1.59%	$82.79	X	98.41%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BPMC with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BLUEPRINT MEDICINES CORPORATION

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by